fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search
News

COVID-19 Booster Shot Increases Protection Against Delta Variant Infection by 85%, Study Indicates

COVID-19 booster shot
A Sheba study suggests that higher levels of antibodies following a third dose of the Pfizer-BioNTech vaccine correlate with a reduced risk of COVID-19 infection.

According to a new Sheba Medical Center and Tel Aviv University study, published in the scientific journal Nature Immunology, the effectiveness of a third COVID-19 vaccine dose against PCR-confirmed infection, regardless of symptoms, is 85.6% higher compared to two doses.

In order to analyze the effectiveness of the third vaccine dose, researchers administered the jab to 12,290 healthcare workers who were not previously infected with COVID-19 and had already received the first and second vaccine doses.
Results indicate that out of the the12,290 participants, 407 (3.3%) tested positive for COVID-19 on a PCR test.

Data gathered as part of the study demonstrated that while the increase in antibodies is relatively small at around 170%, a 600% increase in neutralizing antibodies, which bind pathogens and prevent them from spreading infection, was recorded in comparison to the second vaccine dose.

The study also found that the higher levels of antibodies following a third dose of the Pfizer-BioNTech vaccine correlate with a reduced risk of COVID-19 infection.

Related
News Mar 26.
West Bank and Gaza Medical Professionals Attend a Milestone Sheba Oncology Conference
Highlighting the latest in cancer care, with a particular focus on pediatrics, the Recent Advances in Cancer Care (REACT) 2023 event was attended by over…
Read More
Isenia’s Battle
Isenia’s Battle with Alveolar Sarcoma
At 17, Isenia, a native of Semey, Kazakhstan, noticed a lump on her leg the size of a small apple. Initially, Isenia and her family…
Read More
Colon and Rectal Cancer
News Mar 14.
Sheba Study Indicates Readily-Available Drugs May Prevent Metastasis in Colon and Rectal Cancer Patients
Favorable responses to the treatment were noted by Prof. Shamgar Ben-Eliyahu, a neuroscientist specializing in psychoneuroimmunology (PNI) at TAU’s Sagol School of Neuroscience and School…
Read More